ADAMTS13 and thrombotic thrombocytopenic purpura: Severe deficiency (ADAMTS-13 activity <10%, 1.7%±1.9, indicative of TTP) was found in 91 samples (23.3%) and borderline ADAMTS-13 activity (15.4%±3.0) in 17 (4.4%) samples.